This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/kegg-compound/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/bindingdb/
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB02656/identifier/drugbank/

Statements

Subject Item
n2:DB02656
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n11:DB02656 n16:DB02656
dcterms:title
2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One
adms:identifier
n4:LY2 n5:3973 n6:DB02656 n9:C15195 n12:12915 n13:3835 n14:46504762
n7:IUPAC-Name
n8:271B4BD7-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B4BDD-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B4BDC-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B4BD9-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B4BDA-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B4BDB-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B4BD5-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B4BD3-363D-11E5-9242-09173F13E4C5 n8:271B4BD6-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B4BD4-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B4BE3-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B4BE4-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B4BDE-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B4BDF-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B4BE1-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B4BE0-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B4BE2-363D-11E5-9242-09173F13E4C5
n7:casRegistryNumber
154447-36-6
n7:Bioavailability
n8:271B4BE9-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B4BEB-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B4BEC-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B4BE8-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B4BE7-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B4BEA-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B4BD8-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B4BE5-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B4BE6-363D-11E5-9242-09173F13E4C5